Alembic gains USFDA final approval for Lamotrigine Extended-Release Tablets USP, 200 mg, 250 mg, and 300 mg Read more
Gilead Sciences signs licencing agreements with six companies to manufacture, commercialise Lenacapavir Read more
Sun Pharma and Moebius Medical gain fast track designation for MM-II for the treatment of Osteoarthritis Knee Pain Read more